Kolon Life Science develops cell and gene therapies including Invossa, a cell-mediated gene therapy for osteoarthritis. The company is also engaged in the business of providing active pharmaceuticals ingredients, eco-chemicals including antimicrobial...Show all
Company (Alive / Active)
Phone:
South Korea
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Pharmaceutical composition for preventing or treating osteoarthritis | Jun 29, 2018 | Application | |
Method for assessing validity of cell therapy product | Jun 29, 2018 | Application |